Replies to post #60303 on Biotech Values

[DewDiligence]

IDIX Insider Transactions During Past 24 Months

[Includes transactions through 3/11/08. Please
see #msg-27593338 for current insider holdings.]


PURCHASES

Ron Renaud, CFO
11-Mar-2008 15,000 shares @4.50-4.55

Doug Mayers, CMO
11-Mar-2008 30,000 shares @4.45

John Weidenbruch, Gen Counsel
11-Mar-2008 15,000 shares @4.52-4.59

JP Sommadossi, CEO
9-May-2006 10,000 shares @9.13


SALES

***None***


SEC links:
http://www.sec.gov/Archives/edgar/data/1093649/000120919106029333/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017195/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017843/xslF345X02/doc4.xml
http://www.sec.gov/Archives/edgar/data/1093649/000120919108017844/xslF345X02/doc4.xml

[DewDiligence]

IDIX Insider Shareholdings

[Updated for DEF14a filing on 4/25/08. Note: the
options listed below include all options, whether
vested or not. (Form DEF14a includes only options
that are already vested or vest within 60 days.)]

 
 Executive Officers  
 JP Sommadossi, CEO       2,330K shares  1,406 options 
 Ron Renaud, CFO             15K shares   345K options 
 Doug Mayers, CMO            30K shares   220K options 
 David Standring, EVP Bio      0 shares    70K options 
 John Weidenbruch, Gen Cnsl  15K shares   185K options 
 Paul Fanning, SVP Human Rsrcs 0 shares    40K options 
 -- 
 Six executive officers   2,390K shares 2,266K options

 
 Independent directors  
 Charles Cramb                7K shares   100K options 
 Wayne Hockmeyer             42K shares    60K options 
 Thomas Hodgson              42K shares    60K options 
 Norman Payson                 0 shares    39K options 
 Denise Pollard-Knight         0 shares    40K options 
 Pamela Thomas-Graham          0 shares    75K options 
 -- 
 Six independent dirctrs     91K shares   374K options

 
 All officers/directors   2,481K shares 2,640K options